Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients
- 1 March 2007
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 24 (2) , 387-393
- https://doi.org/10.1007/bf02849908
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Staphylococcus Aureus Infections in Dialysis Patients: Focus on PreventionAsaio Journal, 2000
- Peritoneal InfectionsAdvances in Renal Replacement Therapy, 2000
- “Pulse” Nasal Mupirocin Maintenance Regimen in Patients Undergoing Continuous Ambulatory Peritoneal DialysisInfection Control & Hospital Epidemiology, 1999
- Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.Journal of the American Society of Nephrology, 1996
- A randomized trial of staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampinAmerican Journal of Kidney Diseases, 1996
- Treatment of Staphylococcus aureus Nasal Carriers in Continuous Ambulatory Peritoneal Dialysis With Mupirocin: Long-term ResultsAmerican Journal of Kidney Diseases, 1993
- Randomized Controlled Trial of Prophylactic Rifampin for Peritoneal Dialysis-Related InfectionsAmerican Journal of Kidney Diseases, 1991